hepatitis A virus strain CR 326F antigen, inactivated pediatric/adolescent (HepA) 25 UNT in 0.5 mL Prefilled Syringe
- RxCUI
- 836635
- RxNorm name
- hepatitis A virus strain CR 326F antigen, inactivated pediatric/adolescent (HepA) 25 UNT in 0.5 mL Prefilled Syringe
- Display name
- hepatitis A virus strain CR 326F antigen, inactivated pediatric/adolescent (HepA) 25 UNT in 0.5 mL Prefilled Syringe
- Full name
- hepatitis A virus strain CR 326F antigen, inactivated pediatric/adolescent (HepA) 25 UNT in 0.5 mL Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103606 | Vaqta | Hepatitis A Vaccine Inactivated | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 89191ae9-7f2b-4206-8397-bf7fce3436ac | hepatitis A virus strain CR 326F antigen, inactivated pediatric/adolescent (HepA) 25 UNT in 0.5 mL Prefilled Syringe [PSN] · 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [SCD] · hepatitis A virus strain CR 326F antigen, inactivated 25 UNT per 0.5 ML Prefilled Syringe [SY] | 3 | 28 | These highlights do not include all the information needed to use VAQTA safely and effectively. See full prescribing information for VAQTA. VAQTA ® (Hepatitis A Vaccine, Inactivated) Suspension for Intramuscular Injection Initial U.S. Approval: 1996 | 20250916 |